Dipòsit Digital de Documents de la UAB 42 registres trobats  1 - 10següentfinal  anar al registre: La cerca s'ha fet en 0.01 segons. 
1.
11 p, 2.4 MB Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide / Martinez-Sanchez, Julia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Hamelmann, H. (Berlin Institute of Health. Department of Hematology and Oncology) ; Palomo, Marta (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Mir, Enrique (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Moreno-Castaño, A.B. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Torramade, S. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Rovira, M. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Escolar, G. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Cordes, S. (Berlin Institute of Health. Department of Hematology and Oncology) ; Kalupa, M. (Berlin Institute of Health. Department of Hematology and Oncology) ; Mertlitz, S. (Berlin Institute of Health. Department of Hematology and Oncology) ; Riesner, K. (Berlin Institute of Health. Department of Hematology and Oncology) ; Carreras, E. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Penack, O. (Berlin Institute of Health. Department of Hematology and Oncology) ; Díaz-Ricart, Maribel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
Angiogenesis and endothelial activation and dysfunction have been associated with acute graft-vs. -host disease (aGVHD), pointing to the endothelium as a potential target for pharmacological intervention. [...]
2019 - 10.3389/fimmu.2019.02339
Frontiers in immunology, Vol. 10 (september 2019) , p. 2339  
2.
9 p, 742.8 KB The Genome in a Three-Dimensional Context : Deciphering the Contribution of Noncoding Mutations at Enhancers to Blood Cancer / Rovirosa Mulet, Llorenç (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ramos-Morales, Alberto (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Javierre, BM (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
Associations between blood cancer and genetic predisposition, including both inherited variants and acquired mutations and epimutations, have been well characterized. However, the majority of these variants affect noncoding regions, making their mechanisms difficult to hypothesize and hindering the translation of these insights into patient benefits. [...]
2020 - 10.3389/fimmu.2020.592087
Frontiers in immunology, Vol. 11 (july 2020) , p. 592087  
3.
13 p, 1.1 MB Point-of-care CAR T-cell production (ARI-0001) using a closed semi-automatic bioreactor : Experience from an academic phase i clinical trial / Castella, M. (Blood and Tissue Bank BST) ; Caballero-Baños, M. (Hospital Sant Joan de Déu) ; Ortiz-Maldonado, V. (Hospital Clínic i Provincial de Barcelona) ; González-Navarro, E.A. (Hospital Clínic i Provincial de Barcelona) ; Suñé, G. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Antoñana-Vidósola, A. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Boronat, A. (Hospital Clínic i Provincial de Barcelona) ; Marzal, B. (Hospital Clínic i Provincial de Barcelona) ; Millán, L. (Hospital Clínic i Provincial de Barcelona) ; Martín-Antonio, B. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Cid, J. (Hospital Clínic i Provincial de Barcelona) ; Lozano, M. (Hospital Clínic i Provincial de Barcelona) ; García, E. (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ; Tabera, J. (Hospital Clínic i Provincial de Barcelona) ; Trias, E. (Hospital Clínic i Provincial de Barcelona) ; Perpiña, U. (Universitat de Barcelona. Departament de Ciències Biomèdiques) ; Canals, J.M. (Universitat de Barcelona) ; Baumann, T. (Hospital Clínic i Provincial de Barcelona) ; Benítez-Ribas, D. (Hospital Clínic i Provincial de Barcelona) ; Campo, E. (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Yagüe, J. (Universitat de Barcelona) ; Urbano Ispizua, Álvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rives, S. (Institut de Recerca Sant Joan de Déu) ; Delgado, J. (Centro de Investigación Biomédica en Red de Cáncer) ; Juan, M. (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
Development of semi-automated devices that can reduce the hands-on time and standardize the production of clinical-grade CAR T-cells, such as CliniMACS Prodigy from Miltenyi, is key to facilitate the development of CAR T-cell therapies, especially in academic institutions. [...]
2020 - 10.3389/fimmu.2020.00482
Frontiers in immunology, Vol. 11 (2020) , p. 482  
4.
11 p, 2.0 MB Ethyl Pyruvate Induces Tolerogenic Dendritic Cells / Djedovic, Neda (University of Belgrade. Department of Immunology) ; Mansilla Lopez, Maria Jose (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Jevtić, Bojan (University of Belgrade. Department of Immunology) ; Navarro-Barriuso, Juan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Saksida, Tamara (University of Belgrade. Department of Immunology) ; Martínez-Cáceres, Eva M. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Miljković, Ðorđe (University of Belgrade. Department of Immunology)
Dendritic cells (DC) are professional antigen presenting cells that have a key role in shaping the immune response. Tolerogenic DC (tolDC) have immuno-regulatory properties and they are a promising prospective therapy for multiple sclerosis and other autoimmune diseases. [...]
2019 - 10.3389/fimmu.2019.00157
Frontiers in immunology, Vol. 10 (February 2019) , art. 157  
5.
1.4 MB FHLdb : A Comprehensive Database on the Molecular Basis of Familial Hemophagocytic Lymphohistiocytosis / Viñas-Giménez, Laura (Jeffrey Model Foundation Excellence Center) ; Padilla Sirera, Natàlia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Batlle-Masó, Laura (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Casals, Ferran (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Rivière, Jacques G. (Jeffrey Model Foundation Excellence Center) ; Martínez-Gallo, Mónica (Jeffrey Model Foundation Excellence Center) ; de la Cruz, Xavier (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Colobrán Oriol, Roger (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Background: Primary immunodeficiencies (PIDs) are a heterogeneous group of disorders. The lack of comprehensive disease-specific mutation databases may hinder or delay classification of the genetic variants found in samples from these patients. [...]
2020 - 10.3389/fimmu.2020.00107
Frontiers in immunology, Vol. 11 (january 2020)  
6.
14 p, 1.9 MB MAP7 and MUCL1 are biomarkers of Vitamin D3-induced tolerogenic dendritic cells in multiple sclerosis patients / Navarro-Barriuso, Juan (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Mansilla Lopez, Maria Jose (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Quirant-Sánchez, Bibibana (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Ardiaca-Martínez, Alicia (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Teniente Serra, Aina (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Presas-Rodríguez, Silvia (Universitat Autònoma de Barcelona. Departament de Medicina) ; Ten Brinke, Anja (Amsterdam UMC. University Medical Center) ; Ramo-Tello, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Martínez Cáceres, Eva María (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia)
The administration of autologous tolerogenic dendritic cells (tolDC) has become a promising alternative for the treatment of autoimmune diseases, such as multiple sclerosis (MS). Specifically, the use of vitamin D3 for the generation of tolDC (vitD3-tolDC) constitutes one of the most widely studied approaches, as it has evidenced significant immune regulatory properties, both in vitro and in vivo. [...]
2019 - 10.3389/fimmu.2019.01251
Frontiers in immunology, Vol. 10 (June 2019) , art. 1251  
7.
11 p, 3.6 MB Non-lysosomal activation in macrophages of atlantic salmon (Salmo salar) after infection with piscirickettsia salmonis / Pérez-Stuardo, Diego (Universidad Mayor. Centro de Genómica y Bioinformática) ; Morales-Reyes, Jonathan (Consorcio de Sanidad Acuícola) ; Tapia, Sebastián (Universidad Mayor. Centro de Genómica y Bioinformática) ; Ahumada, Diego E. (Universidad Mayor. Centro de Genómica y Bioinformática) ; Espinoza, Allison (Universidad Mayor. Centro de Genómica y Bioinformática) ; Soto-Herrera, Valentina (Universidad de Santiago de Chile. Centro de Biotecnología Acuícola) ; Brianson, Bernardo (Universidad Mayor. Centro de Genómica y Bioinformática) ; Ibaceta, Valentina (Universidad Mayor. Centro de Genómica y Bioinformática) ; Sandino, Ana María (Universidad de Santiago de Chile. Centro de Biotecnología Acuícola) ; Spencer, Eugenio (Centro de Biotecnología Acuícola. Universidad de Santiago de Chile) ; Vallejos Vidal, Eva Carolina (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Reyes-López, Felipe E. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Valdés, Jorge (Universidad Mayor. Centro de Genómica y Bioinformática) ; Reyes-Cerpa, Sebastián (Universidad Mayor. Centro de Genómica y Bioinformática)
Piscirickettsia salmonis is a facultative intracellular pathogen and etiological agent of the systemic disease salmonid rickettsial septicemia. It has been suggested that P. salmonis is able to survive in host macrophages, localized within a vacuole like-compartment which prevents lysosomal degradation. [...]
2019 - 10.3389/fimmu.2019.00434
Frontiers in immunology, Vol. 10 (March 2019) , art. 434  
8.
17 p, 3.1 MB Human antimicrobial RNases inhibit intracellular bacterial growth and induce autophagy in mycobacteria-infected macrophages / Lu, Lu (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Arranz Trullén, Javier (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Prats-Ejarque, Guillem (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Pulido-Gomez, David (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Bhakta, Sanjib (University of London. Department of Biological Sciences) ; Boix i Borràs, Esther (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
The development of novel treatment against tuberculosis is a priority global health challenge. Antimicrobial proteins and peptides offer a multifaceted mechanism suitable to fight bacterial resistance. [...]
2019 - 10.3389/fimmu.2019.01500
Frontiers in immunology, Vol. 10 (July 2019) , art. 1500  
9.
11 p, 879.8 KB Pertussis prevention : Reasons for resurgence, and differences in the current acellular pertussis vaccines / Esposito, S. (Department of Surgical and Biomedical Sciences. Paediatric Clinic. Università degli Studi di Perugia) ; Stefanelli, P. (Department of Infectious Diseases. Istituto Superiore di Sanità) ; Fry, N.K. (Immunisation and Countermeasures Division. Public Health England-National Infection Service) ; Fedele, G. (Department of Infectious Diseases. Istituto Superiore di Sanità) ; He, Q. (Department of Medical Microbiology. Capital Medical University) ; Paterson, P. (Department of Infectious Disease Epidemiology. Vaccine Confidence Project TM. London School of Hygiene and Tropical Medicine) ; Tan, T. (Division of Pediatric Infectious Diseases. Department of Pediatrics. Northwestern University. Feinberg School of Medicine. Ann and Robert H. Lurie Children's Hospital of Chicago) ; Knuf, M. (Department of Pediatrics. University Medicine) ; Rodrigo Gonzalo de Líria, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Olivier, C.W. (Retired) ; Flanagan, K.L. (Department of Immunology and Pathology. Monash University) ; Hung, I. (Department of Medicine. LKS Faculty of Medicine. University of Hong Kong) ; Lutsar, I. (Department of Microbiology. Institute of Biomedicine and Translational Medicine. University of Tartu) ; Edwards, K. (Division of Pediatric Infectious Diseases. Department of Pediatrics. Vanderbilt University School of Medicine) ; O'Ryan, M. (Microbiology and Mycology Program. Faculty of Medicine. Institute of Immunology and Immunotherapy. University of Chile) ; Principi, N. (Retired) ; Universitat Autònoma de Barcelona
Pertussis is an acute respiratory disease caused by Bordetella pertussis. Due to its frequency and severity, prevention of pertussis has been considered an important public health issue for many years. [...]
2019 - 10.3389/fimmu.2019.01344
Frontiers in immunology, Vol. 10 Núm. JUL (2019) , p. 1344  
10.
12 p, 1.3 MB Regulation of TSHR expression in the thyroid and thymus may contribute to TSHR tolerance failure in graves' disease patients via two distinct mechanisms / Marín-Sánchez, Ana María (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Álvarez de la Sierra, Daniel (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; González, Oscar (Hospital Universitari Vall d'Hebron) ; Lucas-Martin, Ana (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sellés-Sánchez, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rudilla, Francesc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Enrich, E (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Colobrán Oriol, Roger (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Pujol-Borrell, Ricardo (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia)
Graves' disease (GD) involves the presence of agonistic auto-antibodies against the thyrotropin receptor (TSHR), which are responsible for the clinical symptoms. While failure of TSHR tolerance is central to GD pathogenesis, the process leading to this failure remains poorly understood. [...]
2019 - 10.3389/fimmu.2019.01695
Frontiers in immunology, Vol. 10 (July 2019) , art. 1695  

Dipòsit Digital de Documents de la UAB : 42 registres trobats   1 - 10següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.